17 research outputs found
De hemostase (inte)graal
Niet UB, maar tijdelijk ter bevordering van de PDF bestanden in het Leids Repositorium
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease
Item does not contain fulltextPatients with von Willebrand disease (VWD), the most common inherited bleeding disorder, display large variation in bleeding tendency, which is not completely related to VWF levels. The cause of variability in clinical expression is largely unknown. The effect of plasma fibrinolytic capacity on bleeding tendency in VWD patients has not been investigated. We hypothesized that enhanced fibrinolysis may result in a more severe bleeding phenotype. Therefore, we measured the fibrinolytic potential in patients with moderate or severe VWD to investigate the contribution of fibrinolysis to the bleeding tendency. Fibrinolytic potential was measured as plasma clot lysis time (CLT) with and without addition of potato carboxypeptidase inhibitor (PCI) in 638 patients with moderate or severe VWD who participated in a nationwide multicentre cross-sectional study. Bleeding severity was measured using the Bleeding Score (BS).The CLTs were significantly longer, indicative of hypofibrinolysis, in men compared to women with VWD [106.2 (IQR 95.7-118.1) vs. 101.9 (IQR 92.8-114.0) min]. The CLTs prolonged with increasing age. No association was found between VWF or FVIII levels and CLT, or between VWF or FVIII levels and CLT(+PCI) . No association was observed for BS in a model with 10log-transformed CLT, adjusted for age, gender, VWF:Act and FVIII [b = 6.5 (95%CI -0.3 to 13.4)]. Our study showed that the plasma fibrinolytic potential does not influence bleeding tendency in VWD patients and therefore does not explain the variability in bleeding phenotype in VWD.1 mei 201
Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery
Essentials Factor IX (FIX) dosing using body weight frequently results in under and overdosing during surgery. We aimed to establish a population pharmacokinetic (PK) model describing the perioperative FIX levels. Population PK parameter values for clearance and V1 were 284 mL h−170 kg−1 and 5450 mL70 kg−1. Perioperative PK parameters differ from those during non-surgical prophylactic treatment. Summary: Background Hemophilia B is a bleeding disorder characterized by a deficiency of coagulation factor IX (FIX). In the perioperative sett
Early stages of Weibel-Palade body biogenesis revealed by light and electron microscopy
Microscopic imaging and technolog
Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism
Introduction: Microparticles (MPs) carrying active tissue factor (TF) have been detected in the plasma of cancer patients in particular in those presenting with acute deep vein thrombosis (DVT) or pulmonary embolism (PE). Experimental studies in mice have revealed that circulating MPs carrying TF contribute to thrombus formation. Aim: To study whether unselected patients with an acute confirmed PE have elevated TF activity in the MP fraction (MP-TF activity). Materials and Methods: Plasma MP-TF activity was measured in 159 non-selected patients with clinically suspected PE and in 48 healthy controls as previously described. Blood was collected at time of inclusion. The diagnosis of acute PE was confirmed in 54 patients and excluded in 105 patients. Results: Median MP-TF activity in 159 patients with clinically suspected PE was 72 fM Xa/min [range 32-6657] fM Xa/min and higher than in healthy controls (66 [range 28-183] fM Xa/min; P<0.05). There was no significant difference (P=0.169) in MP-TF activity between patients with confirmed PE (median 84.5 fM Xa/min [range 36-2149]) and patients without PE (72 fM Xa/min [range 32-6657]) fM Xa/min). In the 159 patients with clinically suspected PE we observed in an exploratory analysis higher MP-TF activity levels in patients with active cancer (median 137 fM Xa/min [range 36-6657]) and cardiovascular disease (median 131.5 fM Xa/min [range 45-2149]) than in patients without these disorders (P=0.0004 and P=0.014, respectively). Conclusion: In patients presenting with clinically suspected PE plasma MP-TF activity was not associated with confirmed PE. (C) 2010 Elsevier B.V. All rights reserved.Experimental cancer immunology and therap
Time dependent effect of aspirin intake on circadian rhythm of platelet reactivity: a pilot study
Stemcel biology/Regenerative medicine (incl. bloodtransfusion
High rate of postpartum hemorrhage in women with von Willebrand disease or carriership of hemophilia, despite specialized care
Clinical epidemiolog
Aspirin intake AM or PM?: effect on platelet reactivity in the morning
Stemcel biology/Regenerative medicine (incl. bloodtransfusion
Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short term clinical outcome in normotensive patients suspected for having acute pulmonary embolism
Cardiovascular Aspects of Radiolog
Aspirin am or pm?: a randomized cross-over trial
Prevention, Population and Disease management (PrePoD)Public Health and primary car